AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
The U.S. Food and Drug Administration in 2019 approved intranasal esketamine to treat depression in adults. However, little data is available on the use of ketamine or esketamine to treat bipolar ...
Psoriasis is an autoimmune disease that causes your body to overproduce skin cells. It most commonly causes thick, raised skin plaques to develop on your body. When psoriasis affects your nails ...
Driving the news: A study published this week in JAMA Psychiatry looked at patterns in the prevalence of treatment resistant depression (TRD) among the entire population of Taiwan. It found those with ...